Boston-based Ginkgo Bioworks, an organism company, has secured $290 million in Series E financing. The investors included T. Rowe Price Associates, Inc.
Source: Press Release
Boston-based Ginkgo Bioworks, an organism company, has secured $290 million in Series E financing. The investors included T. Rowe Price Associates, Inc.
Source: Press Release
Copyright PEI Media
Not for publication, email or dissemination